George, S., Wang, X., & Pang, H. (2016). Endpoints for Cancer Clinical Trials. In S. George, X. Wang, & H. Pang (Eds.), Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis (pp. 3–36). Chapman & Hall.

George, Stephen, Xiaofei Wang, and Herbert Pang. “Endpoints for Cancer Clinical Trials.” In Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis, edited by Stephen George, Xiaofei Wang, and Herbert Pang, 3–36. Chapman & Hall, 2016.

George S, Wang X, Pang H. Endpoints for Cancer Clinical Trials. In: George S, Wang X, Pang H, editors. Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis. Chapman & Hall; 2016. p. 3–36.

George, Stephen, et al. “Endpoints for Cancer Clinical Trials.” Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis, edited by Stephen George et al., Chapman & Hall, 2016, pp. 3–36.

George S, Wang X, Pang H. Endpoints for Cancer Clinical Trials. In: George S, Wang X, Pang H, editors. Cancer Clinical Trials: Current and Controversial Issues in Design and Analysis. Chapman & Hall; 2016. p. 3–36.